Drug Pipeline

TAF Clinical Trials

Data updated daily from ClinicalTrials.gov — last refresh 2026-06-12
8
Active Studies
4
Recruiting
1
Phase 3
7
Top Sponsors
Active Studies by Phase
Phase 4
4
Phase 3
1
Phase 2
2
Early Phase 1
1
Active Trials
NCT IDTitleConditionStatus
Phase 4
NCT03933384 Tenofovir Alafenamide Versus Entecavir for the Treatment of Chronic Hepatitis B Hepatitis B Recruiting
NCT04496882 Chronic Hepatitis b Patients Switch to tAf After Discontinuation of Nucleoside Analogue Chronic Hepatitis b Active, Not Recruiting
NCT07542951 TAF vs TDF During the Pregancy Hepatitis B Virus Infection; Pregnant Women Enrolling by Invitation
NCT05410496 Tenofovir Alafenamide Switching Therapy in Kidney or Liver Transplant Recipients With… Safety Issues Active, Not Recruiting
Phase 3
NCT07307586 A Small Sample Prospective Clinical Study of Azvudine Tablets to Promote Clinical Cure in… Chronic Hepatitis B Recruiting
Phase 2
NCT02932150 Study of Tenofovir Alafenamide (TAF) in Children and Teen Participants With Chronic… Chronic Hepatitis B Recruiting
NCT05652478 Early Metabolic Effects of Antiretroviral Drugs in Healthy volUnteers: a Phase 2… Healthy Volunteer Recruiting
Early Phase 1
NCT07553767 Efficacy and Safety of Pegylated Interferon Alpha-2β in Patients With Hepatitis B-related… Hepatocellular Carcinoma Not Yet Recruiting
Sponsors Running TAF Trials
Disease Areas
Get alerts when TAF trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free